PMGC Holdings Inc. (ELAB)
ELAB Stock Price Chart
Explore PMGC Holdings Inc. interactive price chart. Choose custom timeframes to analyze ELAB price movements and trends.
ELAB Company Profile
Discover essential business fundamentals and corporate details for PMGC Holdings Inc. (ELAB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
21 Nov 2023
Employees
2.00
Website
https://pmgcholdings.comCEO
Graydon Bensler
Description
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
ELAB Financial Timeline
Browse a chronological timeline of PMGC Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 2 Sept 2025
Shares were split 1 : 3.5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Aug 2025
EPS came in at -$1.61 .
Earnings released on 14 May 2025
EPS came in at -$2.90 , while revenue for the quarter reached $152.38K .
Earnings released on 4 Apr 2025
EPS came in at -$99.99 , while revenue for the quarter reached -$1.75M .
Stock split effective on 10 Mar 2025
Shares were split 1 : 7 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 27 Nov 2024
Shares were split 1 : 200 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Nov 2024
EPS came in at -$97.97 , while revenue for the quarter reached $527.48K .
Earnings released on 14 Aug 2024
EPS came in at -$111.97 , while revenue for the quarter reached $605.53K .
Earnings released on 15 May 2024
EPS came in at -$111.97 , while revenue for the quarter reached $614.56K .
Earnings released on 29 Mar 2024
EPS came in at -$111.97 , while revenue for the quarter reached $698.59K .
Earnings released on 11 Dec 2023
EPS came in at -$0.08 , while revenue for the quarter reached $554.65K .
Earnings released on 30 Jun 2023
EPS came in at -$0.94 , while revenue for the quarter reached $316.53K .
Earnings released on 31 Mar 2023
EPS came in at -$0.79 , while revenue for the quarter reached $142.82K .
Earnings released on 31 Dec 2022
EPS came in at -$0.24 , while revenue for the quarter reached $138.90K .
Earnings released on 30 Sept 2022
EPS came in at -$0.18 , while revenue for the quarter reached $432.12K .
ELAB Stock Performance
Access detailed ELAB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.